[Epidemiology of Invasive Fungal Disease by Filamentous Fungi in the Period 2005 to 2015, in a University Hospital in Santiago, Chile]
Overview
Affiliations
Background: Invasive fungal disease (IFD) due to filamentous fungi is increasingly common.
Aim: To study the epidemiology of EFI in hospitalized adults in our center.
Methods: Retrospective study of adult patients of a university hospital in Santiago, Chile, with EFI due to filamentous fungi between January 2005 and December 2015.
Results: 125 episodes were identified, being 48% proven, 40% probable and 11% possible according to EORTC/MSG criteria, overall incidence was 0.47/1,000 admissions, 57% male patients and age 50 ± 16 years. 66.4% had hematological pathology, 11.2% solid organ transplant, 11.2% rheumatology diseases, 11.2% other conditions. The risk factors were neutropenia 44%, corticosteroid therapy 21%, immunosuppressants 13%. The most frequent mould identified were Aspergillus spp (53.6%), Mucorales (16%), Fusarium spp (8.8%), Alternaria spp (5.6%) and other filamentous (3.2%). All received antifungals, 82% monotherapy, 18% combined therapy, there was surgical defocation in 90% of mucormycosis. The overall mortality was 42%. When comparing 2005-2009 vs 2010-2015, there was a significant increase in incidence and a tendency to lower mortality in the second period.
Conclusions: Over a period of 10 years, we observed an increase in the incidence of EFI by filamentous, aspergillosis was the most frequent etiology and the overall mortality was 42%.
Healthcare Costs of Hospitalizations Due to Aspergillosis and 25-Year Trends in Spain, 1997-2021.
Rincon Villar M, Alonso-Sardon M, Alvarez-Artero E, Rodriguez Alonso B, Lopez-Bernus A, Romero-Alegria A J Fungi (Basel). 2024; 10(11).
PMID: 39590653 PMC: 11595839. DOI: 10.3390/jof10110733.
Wu C, Shu L, Chen Z, Hu Q, Tao L, He C Mycopathologia. 2022; 187(2-3):259-269.
PMID: 35314920 PMC: 9124166. DOI: 10.1007/s11046-022-00623-y.
Goyeneche-Garcia A, Rodriguez-Oyuela J, Sanchez G, Firacative C J Fungi (Basel). 2021; 7(12).
PMID: 34947074 PMC: 8707106. DOI: 10.3390/jof7121092.
COVID-19-Associated Mold Infection in Critically Ill Patients, Chile.
Rabagliati R, Rodriguez N, Nunez C, Huete A, Bravo S, Garcia P Emerg Infect Dis. 2021; 27(5):1454-1456.
PMID: 33760726 PMC: 8084475. DOI: 10.3201/eid2705.204412.